| Descriptor English: | Sodium-Glucose Transporter 2 Inhibitors | ||||||
| Descriptor Spanish: |
Inhibidores del Cotransportador de Sodio-Glucosa 2
| ||||||
| Descriptor Portuguese: | Inibidores do Transportador 2 de Sódio-Glicose | ||||||
| Descriptor French: | Inhibiteurs du cotransporteur sodium-glucose de type 2 | ||||||
| Entry term(s): |
Gliflozin Gliflozins Inhibitor, SGLT-2 Inhibitor, SGLT2 SGLT 2 Inhibitor SGLT 2 Inhibitors SGLT-2 Inhibitor SGLT-2 Inhibitors SGLT2 Inhibitor SGLT2 Inhibitors Sodium Glucose Transporter 2 Inhibitor Sodium Glucose Transporter 2 Inhibitors Sodium-Glucose Transporter 2 Inhibitor |
||||||
| Tree number(s): |
D27.505.519.936 D27.505.696.422.750 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077203 | ||||||
| Scope note: | Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Public MeSH Note: | 2019 |
||||||
| History Note: | 2019 |
||||||
| DeCS ID: | 57538 | ||||||
| Unique ID: | D000077203 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2019/01/01 | ||||||
| Date of Entry: | 2018/07/09 | ||||||
| Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses -
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
|
Sodium-Glucose Transporter 2 Inhibitors
- Preferred
| Concept UI |
M000639744 |
| Scope note | Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. |
| Preferred term | Sodium-Glucose Transporter 2 Inhibitors |
| Entry term(s) |
Gliflozin Gliflozins Inhibitor, SGLT-2 Inhibitor, SGLT2 SGLT 2 Inhibitor SGLT 2 Inhibitors SGLT-2 Inhibitor SGLT-2 Inhibitors SGLT2 Inhibitor SGLT2 Inhibitors Sodium Glucose Transporter 2 Inhibitor Sodium Glucose Transporter 2 Inhibitors Sodium-Glucose Transporter 2 Inhibitor |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
